A citation-based method for searching scientific literature

Michael Weller, Nicholas Butowski, David D Tran, Lawrence D Recht, Michael Lim, Hal Hirte, Lynn Ashby, Laszlo Mechtler, Samuel A Goldlust, Fabio Iwamoto, Jan Drappatz, Donald M O'Rourke, Mark Wong, Mark G Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, Christopher D Turner, Michael J Yellin, Tibor Keler, Thomas A Davis, Roger Stupp, John H Sampson. Lancet Oncol 2017
Times Cited: 409



John H Sampson, Amy B Heimberger, Gary E Archer, Kenneth D Aldape, Allan H Friedman, Henry S Friedman, Mark R Gilbert, James E Herndon, Roger E McLendon, Duane A Mitchell, David A Reardon, Raymond Sawaya, Robert J Schmittling, Weiming Shi, James J Vredenburgh, Darell D Bigner. J Clin Oncol 2010
Times Cited: 515




List of shared articles



Times cited

A review of glioblastoma immunotherapy.
Ravi Medikonda, Gavin Dunn, Maryam Rahman, Peter Fecci, Michael Lim. J Neurooncol 2021
31

Considerations when treating high-grade pediatric glioma patients with immunotherapy.
Erin Crotty, Kira Downey, Lauren Ferrerosa, Catherine Flores, Bindu Hegde, Scott Raskin, Eugene Hwang, Nicholas Vitanza, Hideho Okada. Expert Rev Neurother 2021
3

Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma.
Ketao Jin, Chunsen Mao, Lin Chen, Lude Wang, Yuyao Liu, Jianlie Yuan. Cancers (Basel) 2021
1

Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development.
Bernarda Majc, Metka Novak, Nataša Kopitar-Jerala, Anahid Jewett, Barbara Breznik. Cells 2021
9

Neurosurgical involvement in clinical trials for CNS tumors.
Michael A Vogelbaum, Ian F Parney, J Bradley Elder, Daniel Cahill. J Neurooncol 2021
0

Immunotherapy for recurrent glioblastoma: practical insights and challenging prospects.
Xin Wang, Jie Lu, Gaochao Guo, Jinming Yu. Cell Death Dis 2021
2

Current Immunotherapies for Glioblastoma Multiforme.
Boyuan Huang, Xuesong Li, Yuntao Li, Jin Zhang, Zhitao Zong, Hongbo Zhang. Front Immunol 2021
6

CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma.
Luke Maggs, Giulia Cattaneo, Ali Emre Dal, Ali Sanjari Moghaddam, Soldano Ferrone. Front Neurosci 2021
1

Advances in Immunotherapy for Adult Glioblastoma.
Chirayu R Chokshi, Benjamin A Brakel, Nazanin Tatari, Neil Savage, Sabra K Salim, Chitra Venugopal, Sheila K Singh. Cancers (Basel) 2021
0

Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.
Wei Wu, Jessica L Klockow, Michael Zhang, Famyrah Lafortune, Edwin Chang, Linchun Jin, Yang Wu, Heike E Daldrup-Link. Pharmacol Res 2021
2

EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma.
Aline de Cristo Soares Alves, Vladimir Lavayen, Amanda de Fraga Dias, Franciele Aline Bruinsmann, Juliete Nathali Scholl, Rodrigo Cé, Fernanda Visioli, Ana Maria Oliveira Battastini, Silvia Stanisçuaski Guterres, Fabrício Figueiró,[...]. Nanomedicine (Lond) 2021
0


Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
Yogesh R Suryawanshi, Autumn J Schulze. Viruses 2021
2

Roles of Neutrophils in Glioma and Brain Metastases.
Ya-Jui Lin, Kuo-Chen Wei, Pin-Yuan Chen, Michael Lim, Tsong-Long Hwang. Front Immunol 2021
0

Efficacy and Safety of Actively Personalized Neoantigen Vaccination in the Management of Newly Diagnosed Glioblastoma: A Systematic Review.
Muhammad Khan, Xianming Li, Maosheng Yan, Zihuang Li, Hongli Yang, Guixiang Liao. Int J Gen Med 2021
0

Current Immunotherapeutic Strategies for the Treatment of Glioblastoma.
Mark Dapash, Brandyn Castro, David Hou, Catalina Lee-Chang. Cancers (Basel) 2021
1